Glifempa M 25/500mg Tablets 30’s

$28.80

Glifempa M is a chronic condition drug for nutrition and metabolism in the form of anti-diabetic medicine.

Empiget Glifempa (Empagliflozin) is used to enhance glycemic control in persons with type 2 diabetes mellitus as an addition to diet and exercise.

  • Monotherapy: When diet and exercise alone are insufficient to provide optimal glycemic control in persons for whom metformin is contraindicated owing to intolerance.
  • Add-on combination therapy: When other glucose–lowering medical drugs, such as insulin, together with diet and exercise, do not give appropriate glycemic control, add-on combination treatment is used.
BUY NOW
Click Here to Order Fast the Product
Name
Your Full Name
Field is required!
Field is required!
Email
Your E-mail Address
Field is required!
Field is required!
Phone Number
Your Phonenumber
Invalid phonenumber!
Invalid phonenumber!
Select Country
  • - select a country -
  • Tanzania
  • Kenya
  • Uganda
  • Andorra
  • Angola
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bhutan
  • Bolivia (Plurinational State of)
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cabo Verde
  • Cambodia
  • Cameroon
  • Canada
  • Central African Republic
  • Chad
  • Chile
  • China
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Cyprus
  • Czechia
  • Côte d\'Ivoire
  • Democratic People\'s Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Greece
  • Grenada
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran (Islamic Republic of)
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kuwait
  • Kyrgyzstan
  • Lao People\'s Democratic Republic
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Lithuania
  • Luxembourg
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Mauritania
  • Mauritius
  • Mexico
  • Micronesia (Federated States of)
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Sudan
  • Spain
  • Sri Lanka
  • Sudan
  • Suriname
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • Tajikistan
  • Thailand
  • Timor-Leste
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom of Great Britain and Northern Ireland
  • Tanzania
  • United States of America
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Venezuela (Bolivarian Republic of)
  • Viet Nam
  • Yemen
  • Zambia
  • Zimbabwe
- select a country -
Field is required!
Field is required!
City/Town and Street
Your Town and Street
Field is required!
Field is required!
Your Address
Your Address
Field is required!
Field is required!
Click the Next button to continue to Payment Options
Field is required!
Field is required!
Quantity
Number of Products (Packages)
-
+
Field is required!
Field is required!
https://bongodawa.com/product/glifempa-m-25-500mg-tablets-30s/
Glifempa M 25/500mg Tablets 30’s
glifempa-m-25-500mg-tablets-30s
Field is required!
Field is required!
Glifempa M 25/500mg Tablets 30’s
Field is required!
Field is required!
Current Date is

Field is required!
Field is required!
Current Date
Select todays day Date eg. 25th
  • - select today's date -
  • 1
  • 2
  • 3
  • 4
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
- select today's date -
select today's date
select today's date
Current Month
Select Current Month
  • - select month -
  • January (1)
  • February (2)
  • March (3)
  • April (4)
  • May (5)
  • June (6)
  • July (7)
  • August (8)
  • September (9)
  • October (10)
  • November (11)
  • December (12)
- select month -
please select current month
please select current month
Seelect a Payment Method to Use
Select payment Method
Select payment Method
For Other Payment Methods Like Mastercard, Visa and Amex ,Use the Add to Cart Button Below and Proceed To Checkout in the Cart.

Click the Next button to Finish Payment and Order.
Field is required!
Field is required!

PAYMENT

Pay For your Product through Our TigoPesa LIPA NUMBER


PAY NUMBER - 8062171

PAY NAME - BONGO DAWA 


PAYMENT VERIFICATION

*Please Enter the payment Verification Message sent to your Phone from the Operator Below.

  

Field is required!
Field is required!
Verification Message (Required)
eg. Umetuma TSh ******* kwenda kwa **************. Jumla ya Makato TSh 40. (Ada TSh 30, Tozo TSh 10), VAT TSh 5. Kumbukumbu no.: **********. 18/04/21 10:02.
Please Enter the Correct Full Valid payment Verification Message.
Please Enter the Correct Full Valid payment Verification Message.
Field is required!
Field is required!

PAYMENT

Pay For your Plan through Our M-Pesa Number


PAY NUMBER - 0744 132 580

PAY NAME - Bongo  Graphics Company 


PAYMENT VERIFICATION

*Please Enter the payment Verification Message sent to your Phone from the Operator Below.

  

Field is required!
Field is required!
Verification Message (Required)
eg. Umetuma TSh ******* kwenda kwa **************. Jumla ya Makato TSh 40. (Ada TSh 30, Tozo TSh 10), VAT TSh 5. Kumbukumbu no.: **********. 18/04/21 10:02.
Please Enter the Correct Full Valid payment Verification Message.
Please Enter Verification Message
Senders Phone Number
Write the phone number you used to pay
Phone Number used for payment
Wrong Phone Number
Wrong Phone Number
Field is required!
Field is required!

Description

Glifempa M is a chronic condition drug for nutrition and metabolism in the form of anti-diabetic medicine.

Glifempa pills (Empagliflozin) include empagliflozin, a sodium-glucose co-transporter 2 inhibitor that may be used orally (SGLT2).
Sodium-glucose co-transporter 2 (SGLT2) is the main transporter that allows glucose to be reabsorbed from the glomerular filtrate and returned to the circulation.
Empagliflozin is an SGLT2 inhibitor.
Empagliflozin inhibits SGLT2, which decreases renal reabsorption of filtered glucose and lowers the renal glucose threshold, increasing urine glucose excretion.

Empiget Glifempa (Empagliflozin) is used to enhance glycemic control in persons with type 2 diabetes mellitus as an addition to diet and exercise.

  • Monotherapy: When diet and exercise alone are insufficient to provide optimal glycemic control in persons for whom metformin is contraindicated owing to intolerance.
  • Add-on combination therapy: When other glucose–lowering medical drugs, such as insulin, together with diet and exercise, do not give appropriate glycemic control, add-on combination treatment is used.

HOW TO USE

DOSAGE & ADMINISTRATION:

Monotherapy and add-on combination treatment: The suggested beginning dose for monotherapy and add-on combination therapy with other glucose-lowering medical agents, including insulin, is 10 mg empagliflozin once day with or without meals.

The dose can be raised to 25mg once day in individuals who tolerate 10mg once daily and have an eGFR of 60 ml/min/1.73 m2 and need tighter glycemic control.

The daily maximum dosage is 25mg.

When empagliflozin is used with a sulphonylurea or insulin, a reduced sulphonylurea or insulin dose may be explored to lessen the risk of hypoglycemia.

 

PRECAUTIONS

CONTRAINDICATIONS: Glifempa Empagliflozin is contraindicated in:

  • Patients who have a known hypersensitivity to empagliflozin or any of the product’s excipients.
  • Dialysis, severe renal impairment, or end-stage renal disease

Additional information

Brand

X
Open chat
Ask anything😃. We are Online..